Dallas, TX-A new potential risk marker—monocyte chemoattractant protein-1 (MCP-1)—has been shown to provide independent prognostic value in ACS patients and might also be a good therapeutic target, ...
Atherogenesis is a chronic inflammatory process. Critical in the inflammation process is monocyte chemoattractant protein-1 (MCP-1). To locate genomic regions that affect circulating MCP-1 levels, a ...
TIMP-1 induces Fli-1 expression through miRNA-145, subsequently increasing MCP-1 expression and macrophage recruitment. MiRNA-145-enriched EVs from HSCs can transmit biological information and magnify ...
Study finds evidence that a protein, MCP-1, may determine bone loss responses to parathyroid hormone
In a new study published in November in Scientific Reports, New York University College of Dentistry (NYU Dentistry) researchers investigating the catabolic effect of parathyroid hormone (PTH) in ...
The monocyte chemoattractant protein-1 is a potent cell signaling molecule involved in the activation of mononuclear phagocytes, but its role in the pathogenesis of HIV-associated dementia (HAD) has ...
Researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) have shown, for the first time, that monocyte chemoattractant protein-1 (MCP-1) is required for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results